top of page


Current Status of Cannabis Treatment of Multiple Sclerosis with an Illustrative Case Presentation of a Patient with MS, Complex Vocal Tics, Paroxysmal Dystonia, and Marijuana Dependence Treated with Dronabinol

Deutsch, Stephen I, et al.

CNS Spectrums: The International Journal of Neuropsychiatric Medicine. 2008 May, 13(5): 393-403 (abstract).

Cannabis sativa and dystonia secondary to Wilson’s disease

Roca, Urive, et al.

Movement Disorder Society. 2004 Jan, 20(1): 113-115 (abstract).

Effects of pharmacological manipulations of cannabinoid receptors on severity of dystonia in a genetic model of paroxysmal dyskinesia

Richter, A, et al.

European Journal of Pharmacology. 2002 Nov 15, 454(2-3): 145-151 (abstract). 

A dramatic response to inhaled cannabis in a woman with central thalamic pain and dystonia

Chatteree, Avijit, et al.

Journal of Pain and Symptom Management. 2002 Aug, (abstract). 

Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia

Fox, SH, et al.

Movement Disorders: Official Journal of the Movement Disorder Society. 2002 Jan, 17(1): 145-149 (abstract). 

Cannabis in Movement Disorders

Muller-Vahl, K.R., et al.

Forschende Komplementarmedizin (Research in Complementary Medicine). 1999 Oct, 6(3): 23-27 (abstract). 

(+)-WIN 55,212-2, a novel cannabinoid receptor agonist, exerts antidystonic effects in mutant dystonic hamsters

Richter, Angelika, et al.

European Journal of Pharmacology. 1994 Nov 3, 264(3): 371-377 (abstract).

Open label evaluation of cannabidiol in dystonic movement disorders

Consroe, Paul, et al.

International Journal of Neuroscience. 1986, 30(4): 277-282 (abstract).

Dystonia: About Us
bottom of page